IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 254 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,373,966 | -25.1% | 210,731 | 0.0% | 0.02% | -21.1% |
| Q1 2024 | $1,835,467 | -23.9% | 210,731 | 0.0% | 0.02% | -17.4% |
| Q4 2023 | $2,410,763 | +18.8% | 210,731 | 0.0% | 0.02% | +4.5% |
| Q3 2023 | $2,029,340 | -16.2% | 210,731 | -7.4% | 0.02% | -8.3% |
| Q2 2023 | $2,420,238 | -13.6% | 227,466 | -14.6% | 0.02% | -11.1% |
| Q1 2023 | $2,802,370 | -7.7% | 266,385 | +8.7% | 0.03% | 0.0% |
| Q4 2022 | $3,035,154 | +9.6% | 244,968 | -8.4% | 0.03% | +28.6% |
| Q3 2022 | $2,769,000 | -7.5% | 267,316 | +2.9% | 0.02% | 0.0% |
| Q2 2022 | $2,995,000 | -8.9% | 259,727 | -0.6% | 0.02% | +10.5% |
| Q1 2022 | $3,287,000 | +7.3% | 261,327 | -0.5% | 0.02% | 0.0% |
| Q4 2021 | $3,064,000 | +11.3% | 262,746 | +24.7% | 0.02% | -20.8% |
| Q3 2021 | $2,752,000 | +38.6% | 210,731 | +36.5% | 0.02% | +41.2% |
| Q2 2021 | $1,986,000 | +118.2% | 154,327 | +52.5% | 0.02% | +70.0% |
| Q3 2020 | $910,000 | – | 101,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
| HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
| Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
| BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
| Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
| 13D Management LLC | 658,017 | $7,357,000 | 2.72% |
| Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
| Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
| Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
| PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |